FDA clears innovative blood test for earlier Alzheimer’s diagnosis
The U.S. Food and Drug Administration (FDA) has cleared for marketing an innovative blood test with underlying technology…
Scallop-derived plasmalogens may support brain health and memory
The study, funded by B&S Corporation Co., Ltd., which manufactures and markets scallop plasmalogen, evaluated memory and brain…
AI model predicts cancer subtype, genetic mutations, and survival outcomes across 32 solid tumors
Researchers have developed a novel AI model that can analyze a routine whole histopathology image and simultaneously predict…
Sino Biological launches SuperNuclease® Pro with free trial program
Sino Biological, Inc., a global leader in recombinant technology, announced the launch of SuperNuclease® Pro (Cat#: SSNP02). This…
Researchers train AI to detect diabetes and assign four diagnostic labels
A two-stage AI framework showed strong internal performance across four diabetes-related groups, but its reliance on separate public…
Amyloid beta misfolding predicts Alzheimer’s years before symptoms appear
Widely used Alzheimer’s biomarker P-tau 217 reliably detects the disease only at the clinical stage. The protein misfolding…
Chinese researchers map epigenetic control of congenital heart defects
The findings have direct implications for clinical practice and future research. For genetic screening, the study provides a…
Early electroacupuncture intervention protects pancreatic function in prediabetes
Prediabetes refers to a metabolic state in which blood glucose is higher than normal but has not yet…
Global childhood IBD trends reveal unequal progress in diagnosis and survival
Behind the sharp fall in deaths, three decades of global data reveal uneven progress and a growing need…
Fish oil supplementation during pregnancy changes two childhood brain metabolic markers
A decade after mothers received EPA- and DHA-rich fish oil, MRI scans revealed subtle metabolic differences in their…
New portable strip test accurately detects mosquito-borne viruses
A research team has developed a multisite bridging-mediated lateral flow immunoassay (mbLFIA) that enables highly sensitive, portable detection…
Blood p-tau217 levels signal cognitive impairment risk years before symptoms emerge
A six-cohort analysis links higher baseline p-tau217 to rising 5- and 10-year risks, bringing presymptomatic risk models closer…